Sartorius Stedim Biotech ...

PNK: SDMHF · Real-Time Price · USD
216.65
-3.35 (-1.52%)
At close: May 30, 2025, 3:33 PM

Sartorius Stedim Biotech S.A. Cash Flow Statement

Financials in EUR. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
239.4M 180M 178.9M 178.9M 290.2M 382.8M 578.9M 816.9M 941.2M 1.13B 958.32M 894.32M 813.62M 646.72M 727.13M 660.03M 551.53M
Depreciation & Amortization
308.7M 301.7M 283.6M 283.5M 259.4M 237.6M 231.2M 197.3M 189.6M 181.7M 161.46M 158.66M 149.86M 141.56M 137.08M 123.38M 113.98M
Stock-Based Compensation
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 900K 900K 900K 900K 879K 879K 879K
Other Working Capital
-23.4M -33.4M -32.2M -104.8M -28.5M 59.5M -38.7M 24M -41.3M -133.4M -67.45M -71.35M 40.05M 129.65M 106.62M 122.12M 102.62M
Other Non-Cash Items
97.8M 199.7M 142.3M 72.2M -64.4M -167.9M -174.7M -275.7M -281.3M -348.5M -208.15M -98.75M -55.55M 53.45M -115.35M -128.85M -105.15M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
233.6M 251M 275.5M 185.6M 165.1M 190.7M -5.4M -61.5M -240.8M -351.3M -356.56M -379.06M -246.75M -145.75M -125.68M -64.88M -54.88M
Operating Cash Flow
879.5M 807.6M 755.5M 595.4M 525.5M 643.2M 630M 677M 608.7M 612.3M 555.07M 575.17M 661.17M 695.97M 623.18M 589.68M 505.48M
Capital Expenditures
-295.9M -339.8M -362.6M -401.1M -467M -473.6M -512.7M -512.6M -469.2M -430.6M -426.69M -390.49M -339.19M -323.99M -267.99M -222.19M -195.99M
Cash Acquisitions
n/a n/a n/a -2.22B -2.24B -2.33B -2.32B -580.8M -559.2M -515.6M -523.77M -186.47M -185.27M -141.57M -387.32M -252.72M -470.72M
Purchase of Investments
-100K -100K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
-70.5M -70.5M -72.8M -8.2M -8.2M 79.2M 70.3M 76.2M 76.1M -11.3M -137.25M -209.25M -261.36M -323.56M -222M -186.4M -163M
Investing Cash Flow
-296.1M -340M -365M -2.63B -2.72B -2.72B -2.77B -1.02B -952.3M -957.5M -949.73M -575.63M -523.93M -465.23M -609.42M -439.22M -633.72M
Debt Repayment
-338.2M -875.5M -982.6M 1.27B 1.61B 2.32B 2.38B 574.5M 655.7M 392.4M 420.53M 17.13M -116.17M -5.47M 142.27M 140.57M 330.97M
Common Stock Repurchased
-4.2M -2.2M -2.3M -3.8M 600K n/a -100K 1.4M 1.8M -3.2M -3.6M -6.7M -5.6M n/a n/a n/a n/a
Dividend Paid
-67.1M -67.1M -67.1M -67.1M n/a -132.7M -132.7M -132.7M -248.8M -116.1M -116.12M -116.12M -17K -62.72M -62.74M -94.04M -94.04M
Other Financial Acitivies
-165.7M 1.03B 940.6M 1.07B 1.08B -205.3M -149.5M -149.2M -145.1M -53.5M -6.34M -6.14M -4.94M -3.54M -32.56M -32.66M -33.16M
Financial Cash Flow
-573M 92.4M -6.9M 2.38B 2.79B 2.09B 2.09B 294M 264.7M 220.7M 295.59M -110.71M -126.71M -71.71M 46.97M 13.87M 203.77M
Net Cash Flow
12.5M 562.3M 383.3M 344.1M 601.1M 9.5M -46.2M -46.1M -71.1M -116.5M -81.27M -98.57M 15.73M 163.83M 60.86M 165.36M 79.46M
Free Cash Flow
583.6M 467.8M 392.9M 194.3M 58.5M 169.6M 117.3M 164.4M 139.5M 181.7M 128.38M 184.68M 321.98M 371.98M 355.19M 367.49M 309.49M